🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome

Recruitingn/aAges 18 Years - anyAllSohag University
NCT06673381 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All patients aged 18 Year or older presented by ACS not candidet for primary percutaneus coronary intervention ( PCI ) . Exclusion Criteria: * • Patients aged \< 18 years old * Patients who have eGFR \<60 ml/kg /m2 * Patients who have malignancies * Patients who have chronic heart failure (NYHA class \>II) * Pateints who have chronic liver disease * Patients who have nephrotic syndrome * Patients who have acute cerebrovascular stroke * Pregnant women * Patients who have recent infection
💊

What it tests

  • Not listed
📍

Where

1 site
Sohag faculty of medicine
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy